CLINICAL AND LABORATORY CHARACTERISTICS OF THE EFFECTIVENESS OF DIFFERENT METHODS OF SURGICAL INTERVENTION IN PATIENTS WITH COMPLICATED CHOLEDOCHOLITHIASIS

Authors

DOI:

https://doi.org/10.11603/2414-4533.2025.4.15802

Keywords:

choledocholithiasis, cholangitis, pancreatitis, laboratory parameters, pain syndrome, body temperature, surgical treatment, contrast

Abstract

The aim of the work: to evaluate clinical and laboratory parameters and the postoperative course in patients with complicated choledocholithiasis undergoing different surgical treatments in order to determine the optimal surgical strategy.
Materials and Methods. The study included a clinical examination and analysis of laboratory data of 122 patients with choledocholithiasis (CHL), complicated by cholangitis (CH) and biliary pancreatitis (BP) in the presence of cholelithiasis (CHL), who were hospitalized in the Ternopil City Communal Hospital of Emergency Care. Patients were divided into 2 groups: 1st (n=59) – patients with choledocholithiasis complicated by cholangitis (CHL+CH), 2nd (n=63) – patients with choledocholithiasis complicated by biliary pancreatitis (CHL+BP). Patients in both groups were divided into subgroups depending on the treatment method. The diagnosis of choledocholithiasis complicated by cholangitis was established based on the clinical protocol “Cholelithiasis (CHL)”, Order of the Ministry of Health of Ukraine No. 271 and Tokyo Guidelines 2018. The diagnosis of biliary pancreatitis was determined according to the Japanese recommendations for the management of biliary pancreatitis. Statistical data processing was performed using the Statistica 10.0 program. Absolute indicators were presented as the mean value (Mean) ± standard deviation (SD), and for non-parametric data – as the median (Me) and quartiles. Pearson’s χ² test was used to compare percentages.
Results. Surgery without contrast administration in patients with CHL+CH or CHL+BP was accompanied by a less pronounced inflammatory response, as confirmed by a significant decrease in body temperature 24 and 72 hours after surgery, as well as a decrease in the intensity of pain syndrome 72 hours after surgery (by 1.42 and 1.26 times, respectively; p<0.05–0.001). In patients with CHL+CH, 24 hours after surgery without contrast, a significantly lower level of L-FABP (by 26.09 %) was determined, and after 72 hours, lower levels of L-FABP (by 36.54 %), ALT (by 53.33 %), and total bilirubin (by 53.50 %) compared to the subgroup with contrast. Similar trends were observed in patients with CHL+BP: 24 and 72 hours after surgery without contrast, the levels of GGT, L-FABP and total bilirubin levels were significantly lower (by 58.84–131.25 %), and after 72 hours, ALT (by 32.61 %) and AST (by 21.62 %) activities decreased further compared to the subgroup with contrast.
Conclusions. Refusal of contrast during surgery is clinically appropriate in patients with choledocholithiasis complicated by cholangitis or biliary pancreatitis, as it contributes to a reduction in inflammatory response, pain syndrome, and improvement in biochemical parameters in the early postoperative period.

Author Biographies

N. M. OSTROVSKY, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

Postgraduate (PhD) student, Department of General Surgery

I. M. DEYKALO, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

Postgraduate (PhD) student, Department of General Surgery

References

De Silva WSL, Pathirana AA, Wijerathne TK, Gamage BD, Dassanayake BK, De Silva MM. Epidemiology and disease characteristics of symptomatic choledocholithiasis in Sri Lanka. Ann Hepatobiliary Pancreat Surg. 2019; 23(1):41-5. DOI: 10.14701/ahbps.2019.23.1.41.

Lala V, Zubair M, Minter DA. Liver Function Tests. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482489/ (accessed September 1, 2025).

Moriles KE, Zubair M, Azer SA. Alanine Aminotransferase (ALT) Test. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559278/ (accessed September 1, 2025).

Buxbaum JL, Abbas Fehmi SM, Sultan S, Fishman DS, Qumseya BJ, Cortessis VK, et al. ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis. Gastrointest Endosc. 2019; 89(6):1075-105.e15. DOI: 10.1016/j.gie.2018.10.001.

Shabanzadeh DM, Skaaby T, Sørensen LT, et al. Screen-detected gallstone disease and cardiovascular disease. Eur J Epidemiol. 2017; 32:501-10. DOI: 10.1007/s10654-017-0237-6.

Shabanzadeh DM, Sørensen LT, Jørgensen T. Association between screen-detected gallstone disease and cancer in a cohort study. Gastroenterology. 2017; 152:1965-974.e1. DOI: 10.1053/j.gastro.2017.02.016.

Zheng Y, Xu M, Zheng Y, Xu M, et al. Gallstone disease and increased risk of mortality: two large prospective studies in US men and women. J Gastroenterol Hepatol. 2018; 33:1925-931. DOI: 10.1111/jgh.14212.

Buxbaum JL, Buitrago C, Lee A, Elmunzer BJ, Riaz A, Ceppa EP, et al. ASGE guideline on the management of cholangitis. Gastrointest Endosc. 2021; 94(2):207-21.e14. DOI: 10.1016/j.gie.2021.03.011.

Oh CH, Dong SH. Recent advances in the management of difficult bile-duct stones: a focus on single-operator cholangioscopy-guided lithotripsy. Korean J Intern Med. 2021; 36(2):235-46. DOI: 10.3904/kjim.2020.485.

Ministerstvo okhorony zdorov’ya Ukrayiny [Ministry of Health of Ukraine]. Klinichnyy protokol “Zhovchnokam’yana khvoroba (ZhKKh)” [Clinical protocol “Gallstone disease (GSD)”]. Nakaz MOZ Ukrayiny №271 vid 13.06.2005 r. (v redaktsiyi 2021 r.). Kyiv: MOZ Ukrayiny; 2021. Ukrainian.

Mayumi T, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: Management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018; 25(1):96-100. DOI: 10.1002/jhbp.519.

Takada T, Isaji S, Mayumi T, et al. JPN clinical practice guidelines 2021 with easy-to-understand explanations for the management of acute pancreatitis. J Hepatobiliary Pancreat Sci. 2022; 29:1057-083. DOI: 10.1002/jhbp.1146.

Chaban OO, Khaustova OO, editors. Praktychna psykhosomatyka: diahnostychni shkaly: navchalʹnyy posibnyk [Practical psychosomatics: diagnostic scales: textbook]. 2-he vyd., vypr. i dop. Kyiv: Vydavnychyy dim “Medknyha”; 2019. 112 p. Ukrainian.

Andreucci M, Solomon R, Tasanarong A. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. Biomed Res Int. 2014; 2014:741018. DOI: 10.1155/2014/741018.

Koenig G, Seneff S. Gamma-glutamyltransferase: A predictive biomarker of cellular antioxidant inadequacy and disease risk. Dis Markers. 2015; 2015:818570. DOI: 10.1155/2015/818570.

Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology. 2002; 123:1367-384. DOI: 10.1053/gast.2002.36061.

Ahn KS, Yoon YS, Han HS, Cho JY. Use of liver function tests as first-line diagnostic tools for predicting common bile duct stones in acute cholecystitis patients. World J Surg. 2016; 40:1925-931. DOI: 10.1007/s00268-016-3483-8.

Peery AF, Crockett SD, Murphy CC, Jensen ET, Kim HP, Egberg MD, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2021. Gastroenterology. 2022; 162(2):621-44. DOI: 10.1053/j.gastro.2021.10.020.

Li S, Guizzetti L, Ma C, et al. Epidemiology and outcomes of choledocholithiasis and cholangitis in the United States: trends and urban-rural variations. BMC Gastroenterol. 2023; 23:254. DOI: 10.1186/s12876-023-02868-3.

Li S, Guizzetti L, Ma C, et al. Epidemiology and outcomes of choledocholithiasis and cholangitis in the United States: trends and urban-rural variations. BMC Gastroenterol. 2023; 23:254. DOI: 10.1186/s12876-023-02868-3.

Kwasa EA, Vinayak S, Armstrong R. The role of inflammation in contrast-induced nephropathy. Br J Radiol. 2014; 87(1041):20130738. DOI: 10.1259/bjr.20130738.

Published

2025-12-30

How to Cite

OSTROVSKY, N. M., & DEYKALO, I. M. (2025). CLINICAL AND LABORATORY CHARACTERISTICS OF THE EFFECTIVENESS OF DIFFERENT METHODS OF SURGICAL INTERVENTION IN PATIENTS WITH COMPLICATED CHOLEDOCHOLITHIASIS. Hospital Surgery. Journal Named by L.Ya. Kovalchuk, (4), 40–48. https://doi.org/10.11603/2414-4533.2025.4.15802

Issue

Section

ORIGINAL INVESTIGATIONS